Dec 15 (Reuters) - Liminal BioSciences Inc LMNL.O :
* LIMINAL BIOSCIENCES ANNOUNCES FIRST SUBJECT DOSED IN PHASE 1 MULTIPLE ASCENDING DOSE CLINICAL TRIAL OF FEZAGEPRAS
Dec 15 (Reuters) - Liminal BioSciences Inc LMNL.O :
* LIMINAL BIOSCIENCES ANNOUNCES FIRST SUBJECT DOSED IN PHASE 1 MULTIPLE ASCENDING DOSE CLINICAL TRIAL OF FEZAGEPRAS